This Subcommittee focuses on clinical features and pathophysiology of thrombosis and haemostasis, parameters of coagulation and fibrinolysis, and the etiology, diagnosis and treatments by physicians. This information is provided for experimental researchers, physicians for critical care medicine, hematology gynecology and oncology, and for laboratory scientists, and epidemiologists. The subcommittee also focuses on the constructing standardizing the diagnosis and treatment of coagulation disorder and DIC.
If you are interested in the subcommittee and want to follow its activity, please click "join community" above.
Mandate
- To address issues of practical importance to the research community in the field.
- To evaluate existing data, determine issues for which data is missing or deficient, identify areas of controversy or pressing clinical need and discuss methodologic approaches to answer questions raised.
- To create international collaborations for the purpose of planning and executing projects related to the defined needs in the field.
- To suggest or organize collaborative studies as a result of these activities.
- To generate, publish and distribute reports, recommendations and other documents concerning the above.
- To develop laboratory standards, methods, and nomenclature if appropriate.
If you are a member of the Society and would like to know how to participate in the work of this group, please join the group to receive updates on activity or submit an Expression of Interest Form to the Chairman or any of the Co-Chairmen. We would be pleased to learn of your interest.
Leadership
- Chair - Ecaterina Scarlatescu
- Co-chair - Hunter Moore
- Co-chair - Nathan Nielsen
- Co-chair - Maha Othman
- Co-chair - Daniel O'Reilly
- Co-chair - Jerrold Levy
- Co-chair - Theresa Nwagha
- Co-chair - Yutaka Umemura
Projects
Official Communication